IP Library Granted Patent US 8,256,430
Granted Patent B2
US 8,256,430 · App. 11/957,876 · Granted Sep 4, 2012

Hyperthermia treatment and probe therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,256,430
App. No.
11/957,876
Granted
Sep 4, 2012
Kind
B2
Abstract

A method of using a probe that emits energy to coagulate lesions is disclosed. The probe is constructed and arranged to emit light from its distal end, either at an angle to its longitudinal axis, or along its longitudinal axis. Optionally, an end reflector may be used to direct the energy in a beam to one side of the fiber end. A reinforcing sleeve for the fiber is mounted to a shielded, Piezo-electric motor constructed and arranged to move the fiber both longitudinally and rotationally within an optional elongate cannula. An MRI system is arranged to generate a series of output signals indicative of temperature in the targeted area. The application of energy is stopped when the temperature at the boundary of the lesion reaches the required hyperthermic temperature. Cooling of the tip portion of the probe is effected by expansion of a supplied cooling fluid through a restrictive orifice into an expansion zone at the probe end. The fiber is encased in a stiff tubular titanium probe with a relatively small fluid supply duct inside the probe with the interior of the probe acting as a return duct for the expanded liquid. The temperature of the probe end is monitored by a sensor in the probe end and controlled by controlling the pressure in the supplied cooling fluid.

Claims (15)

1. A method of repairing, reconstructing, coagulating or removing a target tissue comprising:

a) identifying a target that comprises tissue to be repaired, reconstructed, coagulated or removed;

b) percutaneously inserting a probe having a distal end capable emitting energy;

c) positioning said probe such that said distal end is operationally proximate said target tissue;

d) emitting energy from the distal end of the probe sufficient to repair, reconstruct, coagulate or remove said target tissue;

e) moving the distal end of the probe through the target tissue and emitting energy from the distal end, either successively or simultaneously, until the target tissue has been repaired, reconstructed, coagulated or removed; and

f) cooling the distal end of the probe to prevent overheating tissue that is not included in the target tissue by

(i) directing cooling fluid to an expansion zone in the distal end of the probe through a supply duct defined by the probe;

(ii) allowing the cooling fluid to undergo a phase change to gas in the expansion zone; and

(iii) retrieving the gas through a return duct defined by the probe,

wherein emitting energy from the distal end of the probe comprises directing laser energy through an optical fiber contained within the probe and deflecting the laser energy off of a chamfered end of the optical fiber located in the expansion zone.

2. The method of claim 1 further comprising preventing blood from flowing to the target tissue.

3. The method of claim 2 wherein preventing blood from flowing to the target tissue further comprises destroying a lumen of a blood vessel leading to said target tissue by said energy emitted from the distal end of the probe.

4. The method of claim 1 wherein the target tissue is healthy tissue, scar tissue, adipose tissue or a lesion.

5. The method of claim 4 wherein the distal end of said probe is positioned through, adjacent or proximate said target tissue.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Aug 11, 2026
From: TRINITY CAPITAL INC.
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 075615/0671 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2026
From: MADRYN HEALTH PARTNERS, LP
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 073999/0803 →
SECURITY INTEREST Recorded Mar 4, 2026
From: MONTERIS MEDICAL US, INC.; MONTERIS MEDICAL CORPORATION
To: TRINITY CAPITAL INC.
Reel/Frame 073971/0447 →
SECURITY INTEREST Recorded Sep 7, 2022
From: MONTERIS MEDICAL CORPORATION
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 061015/0673 →
RELEASE OF SECURITY INTEREST Recorded Sep 6, 2022
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 061000/0405 →
SECURITY AGREEMENT Recorded Mar 7, 2019
From: MONTERIS MEDICAL CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 048528/0896 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 031091 FRAME 0253. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Aug 28, 2013
From: MONTERIS MEDICAL US, INC.
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 031106/0335 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 031080 FRAME 0829. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Aug 28, 2013
From: MONTERIS MEDICAL INC.
To: MONTERIS MEDICAL US, INC.
Reel/Frame 031106/0271 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2013
From: MONTERIS MEDICAL US, INC.
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 031091/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: MONTERIS MEDICAL INC.
To: MONTERIS MEDICAL US, INC.
Reel/Frame 031080/0829 →